Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-05-020217
Filing Date
2005-04-11
Accepted
2005-04-11 15:51:40
Documents
1
Period of Report
2005-04-07

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 12636
  Complete submission text file 0001209191-05-020217.txt   14505
Mailing Address 251 BALLARDVALE ST WILMINGTON MA 01887
Business Address 261 BALLARDVALE STREET WILMINGTON MA 01867 9786586000
CHARLES RIVER LABORATORIES INTERNATIONAL INC (Issuer) CIK: 0001100682 (see all company filings)

EIN.: 061397316
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O INVERESK RESEARCH GROUP, INC. ELPHINSTONE RESEARCH CENTRE TRANENT, SCOTLAND X0 EH33 2NE
Business Address
BATHGATE BRIAN (Reporting) CIK: 0001226484 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-15943 | Film No.: 05744067